Expression and characterization of the human α2B-adrenoceptor in a vascular smooth muscle cell line

European Journal of Pharmacology

Volumn 587, Issue 1-3, 2008, Pages 48-56

  Huhtinen, Anna ^a   Scheinin, Mika ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TYKSLAB ^*  (Finland)

Author keywords

2B adrenoceptor; 35S GTP S binding; A7r5; Dexmedetomidine; Nucleofection; Proliferation; Stable expression

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR ALPHA2B; ALPHA ACTIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MEMBRANE PROTEIN; TRITIUM;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DNA SYNTHESIS; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; WILD TYPE;

BIOTRANSFORMATION; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; DATA INTERPRETATION, STATISTICAL; FLUORESCENT ANTIBODY TECHNIQUE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; PROTEIN BINDING; RECEPTOR, ADENOSINE A2B; THYMIDINE;

EID: 44149101681     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.03.049     Document Type: Article

References (68)

1. Altman J.D., Trendelenburg A.U., MacMillan L., Bernstein D., Limbird L., Starke K., Kobilka B.K., and Hein L. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol. Pharmacol. 56 (1999) 154-161
2. Björk S., Vainio M., and Scheinin M. Uneven cellular expression of recombinant alpha2A-adrenoceptors in transfected CHO cells results in loss of response in adenylyl cyclase inhibition. Biochim. Biophys. Acta 1744 (2005) 38-46
3. Bochaton-Piallat M.L., Ropraz P., Gabbiani F., and Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 815-820
4. 2-adrenergic stimulation promotes preadipocyte proliferation. Involvement of mitogen-activated protein kinases. J. Biol. Chem. 269 (1994) 30254-30259
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72 (1976) 248-254
6. Brede M., Nagy G., Philipp M., Sorensen J.B., Lohse M.J., and Hein L. Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol. Endocrinol. 17 (2003) 1640-1646
7. Bücheler M.M., Hadamek K., and Hein L. Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience 109 (2002) 819-826
8. Castan I., Valet P., Larrouy D., Voisin T., Remaury A., Daviaud D., Laburthe M., and Lafontan M. Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system. Am. J. Physiol. 265 (1993) E74-E80
9. 2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am. J. Physiol, Heart Circ. Physiol. 278 (2000) H1075-H1083
10. Chotani M.A., Mitra S., Su B.Y., Flavahan S., Eid A.H., Clark K.R., Montague C.R., Paris H., Handy D.E., and Flavahan N.A. Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H59-H67
11. Chotani M.A., Mitra S., Eid A.H., Han S.A., and Flavahan N.A. Distinct cAMP signaling pathways differentially regulate alpha2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. Am. J. Physiol, Heart Circ. Physiol. 288 (2005) H69-H76
12. 2B-adrenergic receptors activate MAPK and modulate proliferation of primary cultured proximal tubule cells. Am. J. Physiol., Renal Fluid Electrolyte Physiol. 282 (2002) F943-F952
13. 2-adrenergic receptors. Mol. Pharmacol. 51 (1997) 711-720
14. Dinenno F.A., and Joyner M.J. Combined NO and PG inhibition augments alpha-adrenergic vasoconstriction in contracting human skeletal muscle. Am. J. Physiol, Heart Circ. Physiol. 287 (2004) H2576-H2584
15. Docherty J.R. Review: Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur. J. Pharmacol. 361 (1998) 1-15
16. 2-adrenergic receptor subtypes in a cell type-specific manner. J. Biol. Chem. 267 (1992) 24045-24052
17. 2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 267 (1992) 15795-15801
18. Eid A.H., Maiti K., Mitra S., Chotani M.A., Flavahan S., Bailey S., Thompson-Torgerson C.S., and Flavahan N.A. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries. Am. J. Physiol, Heart Circ. Physiol. 293 (2007) H1955-H1961
19. 2-adrenoceptors to second messenger pathways. J. Neurochem. 66 (1996) 2394-2401
20. Figueroa X.F., Poblete M.I., Boric M.P., Mendizabal V.E., Adler-Graschinsky E., and Huidobro-Toro J.P. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br. J. Pharmacol. 134 (2001) 957-968
21. Firulli A.B., Han D., Kelly-Roloff L., Koteliansky V.E., Schwartz S.M., Olson E.N., and Miano J.M. A comparative molecular analysis of four rat smooth muscle cell lines. In Vitro Cell. Dev. Biol. 34 (1998) 217-226
22. Flavahan N.A., Flavahan S., Liu Q., Wu S., Tidmore W., Wiener C.M., Spence R.J., and Wigley F.M. Increased α2-adrenergic constriction of isolated arterioles in diffuse scleroderma. Arthritis Rheum. 43 (2000) 1886-1890
23. Graves D.C., and Yablonka-Reuveni Z. Vascular smooth muscle cells spontaneously adopt a skeletal muscle phenotype: a unique Myf5-/MyoD+ myogenic program. J. Histochem. Cytochem. 48 (2000) 1173-1194
24. Guimaraes S., and Moura D. Vascular adrenoceptors: an update. Pharmacol. Rev. 53 (2001) 319-356
25. Hall J.L., Chatham J.C., Eldar-Finkelman H., and Gibbons G.H. Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Diabetes 50 (2001) 1171-1179
26. 3H]RX821002 as radioligands. Biochim. Biophys. Acta 1266 (1995) 207-214
27. Happe H.K., Bylund D.B., and Murrin L.C. Alpha-2 adrenergic receptor functional coupling to G proteins in rat brain during postnatal development. J. Pharmacol. Exp. Ther. 288 (1999) 1134-1142
28. 35S]-GTPγS binding assay: approaches and applications in pharmacology. Life Sci. 74 (2003) 489-508
29. Hurt C.M., Feng F.Y., and Kobilka B. Cell-type specific targeting of the alpha2c-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. J. Biol. Chem. 275 (2000) 35424-35431
30. Iversen N., Birkenes B., Torsdalen K., and Djurovic S. Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells. Genet. Vaccines Ther. 3 (2005) 2
31. 2-adrenoceptor subtypes to regulation of cAMP-production in transfected S115 cells. Eur. J. Pharmacol. 266 (1994) 165-174
32. 2B-C2 expressed in Sf9 cells couple to signal transduction pathways resulting in opposite effects on cAMP production. Eur. J. Pharmacol. 290 (1995) 75-83
33. Johnson B.D., Gershan J.A., Natalia N., Zujewski H., Weber J.J., Yan X., and Orentas R.J. Neuroblastoma cells transiently transfected to simultaneously express the co-stimulatory molecules CD54, CD80, CD86, and CD137L generate antitumor immunity in mice. J. Immunother. 28 (2005) 449-460
34. 2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activites. Hepatology 35 (2002) 1329-1340
35. Karkoulias G., Mastrogianni O., Ilias I., Lymperopoulos A., Taraviras S., Tsopanoglou N., Sitaras N., and Flordellis C.S. Alpha2-adrenergic receptors decrease DNA replication and cell proliferation and induce neurite outgrowth in transfected rat pheochromocytoma cells. Ann. N.Y. Acad. Sci. 1088 (2006) 335-345
36. Kimes B.W., and Brandt B.L. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp. Cell Res. 98 (1976) 349-366
37. 2-adrenoceptors in opossum kidney cells couple to stimulation of MAPK independently of adenylyl cyclase inhibition. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 225-232
38. Lee M., Rentz J., Han S.O., Bull D.A., and Kim S.W. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther. 10 (2003) 585-593
39. Lemire J.M., Covin C.W., White S., Giachelli C.M., and Schwartz S.M. Characterization of cloned aortic smooth muscle cells from young rats. Am. J. Pathol. 144 (1994) 1068-1081
40. Link R.E., Desai K., Hein L., Stevens M.E., Chruscinski A., Bernstein D., Barsh G.S., and Kobilka B.K. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273 (1996) 803-805
41. Marjamäki A., Frang H., Pihlavisto M., Hoffren A.M., Salminen T., Johnson M.S., Kallio J., Javitch J.A., and Scheinin M. Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human alpha(2A)-adrenergic receptor. J. Biol. Chem. 274 (1999) 21867-21872
42. 2-adrenoceptors in PC12 cells. J. Neurosci. 19 (1999) 9281-9288
43. 2-adrenoceptor subtypes: dependence on receptor subtype and employed agonist. Eur. J. Cell Biol. 82 (2003) 231-239
44. Olli-Lähdesmäki T., Tiger M., Vainio M., Scheinin M., and Kallio J. Ligand-induced alpha2-adrenoceptor endocytosis: relationship to Gi protein activation. Biochem. Biophys. Res. Commun. 321 (2004) 226-233
45. 2B-adrenoceptors mediates cardiovascular effects of etomidate. Anesthesiology 99 (2003) 889-895
46. Patterson, W.C., Lee, M.-E., Haber, E., 1999. Endothelial cell-specific promoter, US patent 5888765.
47. 2-adrenoceptors. Eur. J. Pharmacol. 355 (1998) 275-279
48. 2-adrenergic receptor subtypes to cyclic-AMP-dependent reporter gene expression in transiently transfected JEG-3 cells. Mol. Pharmacol. 44 (1993) 802-809
49. 2-adrenergic receptor subtype diversity: one receptor is not enough. Am. J. Physiol., Regul. Integr. Comp. Physiol. 283 (2002) R287-R295
50. Piascik M.T., Soltis E.E., Piascik M.M., and Macmillan L.B. α-Adrenoceptors and vascular regulation: molecular, pharmacological and clinical correlates. Pharmacol. Ther. 72 (1996) 215-241
51. Pohjanoksa K., Jansson C.C., Luomala K., Marjamäki A., Savola J.M., and Scheinin M. Alpha2-adrenoceptor regulation of adenylyl cyclase in CHO cells: dependence on receptor density, receptor subtype and current activity of adenylyl cyclase. Eur. J. Pharmacol. 335 (1997) 53-63
52. 2-Adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am. J. Physiol., Cell Physiol. 274 (1998) C654-C662
53. Rohrer D.K., and Kobilka B.K. Insights from in vivo modification of adrenergic receptor gene expression. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 351-373
54. Sabol L.S., and Nirenberg M. Regulation of adenylate cyclase of neuroblastoma glioma hybrid cells by α-adrenergic receptors. J. Biol. Chem. 254 (1979) 1913-1920
55. Schaak S., Cussac D., Cayla C., Devedjian J.C., Guyot R., Paris H., and Denis C. Alpha2 adrenoceptors regulate proliferation of human intestinal epithelial cells. Gut 47 (2000) 242-250
56. 2-adrenergic receptors does not require agonist-elicited endocytosis. J. Biol. Chem. 274 (1999) 24935-24940
57. Sen S., Jaakola V.P., Heimo H., Engstrom M., Larjomaa P., Scheinin M., Lundstrom K., and Goldman A. Functional expression and direct visualization of the human alpha 2B -adrenergic receptor and alpha 2B-AR-green fluorescent fusion protein in mammalian cell using Semliki Forest virus vectors. Protein Expr. Purif. 32 (2003) 265-275
58. Seuwen K., Magnaldo I., Kobilka B.K., Caron M.G., Regan J.W., Lefkowitz R.J., and Pouyssegur J. Alpha 2-adrenergic agonists stimulate DNA synthesis in Chinese hamster lung fibroblasts transfected with a human alpha 2-adrenergic receptor gene. Cell Regul. 1 (1990) 445-451
59. Talke P.O., Lobo E., and Brown R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology 99 (2003) 65-70
60. 2-adrenergic receptors - lessons from knockouts. In: Perez D.M. (Ed). The Adrenergic Receptors in the 21st Century (2006), Humana Press, Totowa, New Jersey 241-265
61. Thiel C., and Nix M. Efficient transfection of primary cells relevant for cardiovascular research by nucleofection. Methods Mol. Med. 129 (2006) 255-266
62. Vazquez S.M., Mladovan A.G., Perez C., Bruzzone A., Baldi A., and Luthy I.A. Human breast cancer cell lines exhibit functional alpha2-adrenoceptors. Cancer Chemother. Pharmacol. 58 (2006) 50-61
63. Villaschi S., Nicosia R.F., and Smith M.R. Isolation of a morphologically and functionally distinct smooth muscle cell type from the intimal aspect of the normal rat aorta. Evidence for smooth muscle cell heterogeneity. In Vitro Cell. Dev. Biol., Anim. 30A (1994) 589-595
64. von Zastrow M., Link R.E., Daunt D., Barsh G., and Kobilka B. Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J. Biol. Chem. 268 (1993) 763-766
65. Wang S., Desai D., Wright G., Niles R.M., and Wright G.L. Effects of protein kinase C alpha overexpression on A7r5 smooth muscle cell proliferation and differentiation. Exp. Cell Res. 236 (1997) 117-126
66. Winslow J.-W., Bradley J.D., Smith J.A., and New E.J. Reactive sulfhydryl groups of alpha 39, a guanine nucleotide-binding protein from brain. Location and function. J. Biol. Chem. 262 (1987) 4501-4507
67. Wozniak M., and Limbird L.E. Trafficking itineraries of G protein-coupled receptors in epithelial cells do not predict receptor localization in neurons. Brain Res. 780 (1998) 311-322
68. Zant-Przeworska E., Kamps J.A., Roks A.J., Gilst W.H., and Scherphof G.L. Development of liposomal gene targeting for therapeutic intervention or prevention of restenosis. Cell. Mol. Biol. Lett. 7 (2002) 268-269